Effects of long-term propranolol and octreotide on postprandial hemodynamics in cirrhosis: A randomized, controlled trial

Gastroenterology

Volumn 122, Issue 4, 2002, Pages 916-922

  Vorobioff, Julio D ^a   Gamen, Marcelo ^a   Kravetz, David ^b   Picabea, Eduardo ^a   Villavicencio, Roberto ^a   Bordato, Juan ^a   Ruf, Andrés ^a   Bessone, Fernando ^a   Romero, Gustavo ^b   Palazzi, Jorge ^c   Nicora, Alicia ^c   Passamonti, María ^a   Tanno, Hugo ^a  

^a Sanatorio Parque   (Argentina)

^b HOSPITAL DE GASTROENTEROLOGÍA DR CARLOS BONORINO UDAONDO   (Argentina)

^c Instituto de Estudios Bioquã micos   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; PROPRANOLOL;

ADULT; ARGENTINA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; ESOPHAGUS VARICES BLEEDING; FEMALE; HEART INDEX; HEMODYNAMICS; HUMAN; LIVER CIRRHOSIS; LONG TERM CARE; MALE; PORTAL VEIN BLOOD PRESSURE; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULAR RESISTANCE;

EID: 0036202244     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.32395     Document Type: Article

References (39)

1. The effects of oral feeding of meat and glucose on hepatic vein wedge pressure in normal and cirrhotic subjects
2. Postprandial hemodynamic responses in patients with cirrhosis
3. Effect of meal on portal hemodynamics in healthy humans and in patients with chronic liver disease
4. The effect of non-protein liquid meals on the hepatic venous pressure gradient in patients with cirrhosis
5. Evaluation of postprandial hyperemia in superior mesenteric artery and portal vein in healthy and cirrhotic humans: An operator-blind echo-Doppler study
6. Postprandial changes in portal hemodynamics in patients with cirrhosis
7. Splanchnic and overall cardiovascular hemodynamics during eating and digestion
8. The effect of oral protein and glucose feeding on splanchnic blood flow and oxygen utilization in normal and cirrhotic subjects
9. Possible mechanisms for the initiation and maintenance of post-prandial intestinal hyperemia
10. Octreotide: A long-acting inhibitor of endogenous hormone secretion for human metabolic investigations
11. Hemodynamic factors involved in the development and rupture of esophageal varices: A pathophysiologic approach to treatment
12. Effects of propranolol on hepatic blood flow in normal and portal hypertensive rats
13. Effects of selective blockade of beta 2-adrenergic receptors on portal and systemic hemodynamics in a portal hypertensive rat model
14. Daily variation in portal blood flow and the effect of propranolol administration in a randomized study of patients with cirrhosis
15. Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis
16. A randomized study of propranolol on postprandial portal hyperemia in cirrhotic patients
17. Effect on hemodynamics of a liquid meal alone and in combination with propranolol in cirrhosis
18. Effects of propranolol on post-prandial increases in portal venous pressure in patients with portal hypertension
19. Octreotide
20. A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal hemorrhage
21. Octreotide inhibits the meal-induced increases in the portal vein pressure of cirrhotic patients with portal hypertension: A double-blind, placebo-controlled study
22. Octreotide blunts portaprandial splanchnic hyperemia in cirrhotic patients: A double-blind randomized echo-doppler study
23. Fasting and post-prandial splanchnic blood flow is reduced by a somatostatin analogue (octreotide) in man
24. Octreotide prevents postprandial splanchnic hyperemia in patients with portal hypertension
25. Octreotide long-term treatment in patients with portal hypertension: Persistent inhibition of postprandial glucagon response without major changes in renal function
26. Transection of the oesophagus for bleeding oesophageal varices
27. Wedged and free hepatic venous pressure measured with a balloon catheter
28. Local arterial vasoconstriction induced by octreotide in patients with cirrhosis
29. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices
30. Effect of exogenous somatostatin infusion on gastrointestinal blood flow and hormones in the conscious dog
31. Effect of somatostatin analogue (SMS 201-995, Sandostatin) on pancreatic secretion in humans
32. Hemodynamic effects of glucagon in portal hypertension
33. Effects of food intake and various intrinsic hormones on portal blood flow in patients with liver cirrhosis demonstrated by pulsed Doppler with the Octoson
34. Mesenteric vasoactivity associated with eating and digestion in the conscious dog
35. Octreotide potentiates PKC-dependent vasoconstriction in splanchnic arteries in portal-hypertensive and control rats
36. 2-adrenergic receptors on portal and systemic hemodynamics in a portal hypertensive rat model
37. Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension
38. Postprandial alterations in hemodynamics and blood pressure in normal subjects
39. Central hemodynamic changes after a meal